News Releases

Oculis to Present at the Stifel 2024 Healthcare Conference

Oculis Reports Q3 2024 Financial Results and Provides Company Updates

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

Oculis to Present at Upcoming September Investor Conferences

Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update

Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer

Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference